Lutnick discusses drug prices in meeting with Eli Lilly CEO
Published on 03/10/2026 at 05:10 pm EDT
Reuters
Share
Share
|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 930.39 USD | -0.97% |
|
+0.23% | -13.54% |
David A. Ricks is a businessperson who has been the head of 7 different companies is on the board of Adobe, Inc. and The Central Indiana Corporate Partnership and Chairman, President & Chief Executive Officer of Eli Lilly & Co., Chairman for Pharmaceutical Research & Manufacturers of America, President for International Federation of Pharmaceutical Manufacturers, Member of The Business Roundtable, Member of The Business Council and Chairman-Governors Board at James Whitcomb Riley Children's Foundation. In his past career he held the position of Principal at HP, Inc., Principal at International Business Machines Corp., President for Lilly USA LLC, President & General Manager at Lilly Industries Shanghai Ltd. and General Manager of Eli Lilly Canada, Inc. David A. Ricks received an MBA from Indiana University and an undergraduate degree from Purdue University.
Employees
50,000
Sector
Pharmaceuticals
Trader
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
A
Sell
Buy
Mean consensus
BUY
Number of Analysts
31
Last Close Price
939.47USD
Average target price
1,209.69USD
Spread / Average Target
+28.76%
Quarterly revenue - Rate of surprise
- Stock Market
- Stock Market News
- Lutnick discusses drug prices in meeting with Eli Lilly CEO
Select your edition
All financial news and data tailored to specific country editions
